Table 1: Types of malignancy at baseline.

Cancer typeITT subjects
( subjects)

Pancreatic45 (77.6%)
Cholangiocarcinoma3 (5.2%)
Ampullary2 (3.4%)
Colon2 (3.4%)
Lung2 (3.4%)
Other undefined malignancy
 Retroperitoneal mass, suspect sarcoma
 Malignant adenopathy of the porta hepatic portacaval, and pericardial regions4 (6.9%)
 Peripancreatic malignant lymphadenopathy
 Lymphoma to porta hepatis